| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |